Control Group

Alendronate Group

Calcitonin Group

Raloxifene Group

F-value

P-value

Number of cases

39

39

39

39

Age (yr)

70.5 ± 8.4

67.8 ± 9.3

67.4 ± 8.1

68.4 ± 7.4

1.087

0.356

BMI

22.25 ± 0.123

22.07 ± 3.06

21.88 ± 2.88

2.39 ± 2.66

0.231

0.875

L_2-4BMD

0.792 ± 0.123

0.793 ± 0.12

0.783 ± 0.102

0.797 ± 0.110

0.101

0.859

Femoral neck BMD

0.606 ± 0.087

0.613 ± 0.108

0.583 ± 0.195

0.604 ± 0.088

0.396

0.756

Pre-treatment VAS

1.51 ± 0.601

1.54 ± 0.682

1.46 ± 0.682

1.36 ± 0.584

0.601

0.615

Pre-treatment CCR

56.232 ± 16.10

58.64 ± 14.00

60.81 ± 14.77

61.07 ± 12.04

1.119

0.343

Pre-treatment Ca

2.30 ± 0.07

2.31 ± 0.11

2.32 ± 0.10

2.29 ± 0.09

1.38

1.25

β-cross

0.427 ± 0.166

0.424 ± 0.162

0.415 ± 0.122

0.419 ± 0.121

0.025

0.995